Breast Biopsy Market Size & Share, by Product (Biopsy Needles, Biopsy Tables, Biopsy Wires); End-user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 747
  • Published Date: Aug 02, 2023
  • Report Format: PDF, PPT

Companies Dominating the Breast Biopsy Landscape

top-features-companies
    • Hologic, Inc.
    • Company Overview
    • Business Strategy
    • Key Product Offerings
    • Financial Performance
    • Key Performance Indicators
    • Risk Analysis
    • Recent Development
    • Regional Presence
    • SWOT Analysis
    • Danaher Corporation
    • BD (Becton, Dickinson, and Company)
    • Cook Medical LLC
    • Argon Medical Devices, Inc.
    • B. Braun Melsungen AG
    • C.R. Bard, Inc.
    • Devicor Medical Products, Inc.
    • Cardinal Health, Inc.

Browse Key Market Insights with Data Illustration:

In-the-news

In The News

  • Hologic Inc, Hologic announced that its subsidiary, Biotheranostics, received a positive coverage determination from Medicare for Its Breast Cancer Index genomic test. The Breast Cancer Index test is used to predict the likelihood of recurrence in early-stage, hormone receptor-positive breast cancer patients.
  • BD (Becton, Dickinson, and Company). BD announced the launch of the BO Intevia 1mL two-step disposable autoinjector, which is used for the subcutaneous injection of biological drugs. The device is designed to enhance patient experience and medication adherence by providing a reliable, easy-to-use, and customizable Infection experience. The BD Intevia autoinjector is part of the company's broader portfolio of products for drug delivery and administration.

Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 747
  • Published Date: Aug 02, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The growing incidence of breast cancer and the expansion of healthcare spending are some of the major factors anticipated to drive the growth of the breast biopsy market.

The market is anticipated to attain a CAGR of ~6% over the forecast period, i.e., 2023 – 2035.

The major players in the market are Danaher Corporation, BD (Becton, Dickinson, and Company), Cook Medical LLC, Argon Medical Devices, Inc., B. Braun Melsungen AG, C.R. Bard, Inc., and others.

The hospital segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.

The market in Asia Pacific is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying